Oncoclínicas (ONCO3) announced on Tuesday, November 10, 2026, that it will postpone the release of its Quarterly Information (ITR) for the third quarter of 2026 (3Q26), covering the three- and nine-month periods ended September 30. The postponement is because the Independent Special Committee, created by the Board of Directors on August 25, 2026, has not yet completed its work. The company will not be able to meet the regulatory filing deadline.
The committee was mentioned in a Material Fact released on October 14, 2026. According to Oncoclínicas, the estimated deadline for completing the work is the third week of December 2026.
The 3Q26 earnings conference call will also not be held on the originally scheduled date. The date will be reassessed after the financial information is released.
Oncoclínicas estimates it will release the 3Q26 ITR by the third week of December 2026. Management says it believes it is possible to release the information before the end of that period. The company says it will keep shareholders and the market informed of relevant updates.
